Wolverine Trading’s Humacyte HUMA Stock Holding History

Wolverine Trading’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$97.9K	Buy	+56,600	New	+$111K	﹤0.01%	5210
2025 Q2	–	Sell	-60,600	Closed	-$119K	–	5106
2025 Q1	$119K	Buy	60,600 +22,300	+58%	+$83.7K	﹤0.01%	4169
2024 Q4	$195K	Buy	38,300 +10,400	+37%	+$51.5K	﹤0.01%	4538
2024 Q3	$156K	Buy	27,900 +7,500	+37%	+$49.4K	﹤0.01%	4214
2024 Q2	$97.9K	Sell	20,400 -9,600	-32%	-$50K	﹤0.01%	4073
2024 Q1	$93.3K	Buy	+30,000	New	+$101K	﹤0.01%	4070
2022 Q4	–	Sell	-14,800	Closed	-$50K	–	4430
2022 Q3	$50K	Buy	+14,800	New	+$56.8K	﹤0.01%	4135
2022 Q1	–	Sell	-17,300	Closed	-$126K	–	5838
2021 Q4	$126K	Buy	17,300 +2,500	+17%	+$24.7K	﹤0.01%	4982
2021 Q3	$177K	Buy	+14,800	New	+$169K	﹤0.01%	5431

Other funds holding HUMA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wolverine Trading's HUMA Position: Q3 2025 in Review

Wolverine Trading opened a new position in Humacyte (HUMA) in Q3 2025: 22,143 shares worth $38.3K. The stake represents ﹤0.01% of the portfolio and ranks #5470 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in HUMA as recently as Q4 2024.

Wolverine Trading first reported a position in HUMA in Q3 2023 and has held it in 7 quarters since. The position peaked at $303K in Q3 2024. 141 funds tracked by Wall St. Rank hold HUMA as of Q3 2025.

Wolverine Trading held 22,143 shares of Humacyte worth $38.3K as of Q3 2025.
Humacyte was a new Wolverine Trading position in Q3 2025.
Humacyte made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5470 holding.
Wolverine Trading first reported a position in Humacyte in Q3 2023 and has held it in 7 quarters since.
Wolverine Trading's Humacyte position peaked at $303K in Q3 2024.
141 funds tracked by Wall St. Rank held Humacyte as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.